• Explore /
  • Poster
  • / DETECT III/IV: Two combined clinical trials based on the phenotype of circulating tumor cells (CTCs).

DETECT III/IV: Two combined clinical trials based on the phenotype of circulating tumor cells (CTCs).

Abstract Poster

Authors

null

Susanne Albrecht

Universitätsfrauenklinik Ulm, Ulm, Germany

Susanne Albrecht , Fabienne Schochter , Carola Anna Melcher , Carsten Hagenbeck , Thomas W. P. Friedl , Bernadette Jaeger , Brigitte Kathrin Rack , Volkmar Mueller , Peter A. Fasching , Wolfgang Janni , Tanja N. Fehm

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Tumor Biology

Track

Tumor Biology

Sub Track

Circulating Tumor Cells

Clinical Trial Registration Number

NCT01619111/ NCT02035813

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr TPS11132)

DOI

10.1200/jco.2014.32.15_suppl.tps11132

Abstract #

TPS11132

Poster Bd #

414A

Abstract Disclosures

Similar Posters

Poster

2016 ASCO Annual Meeting

The DETECT study concept: Individualized therapy of metastatic breast cancer.

The DETECT study concept: Individualized therapy of metastatic breast cancer.

First Author: Arkadius Polasik

First Author: Amelie Schramm

First Author: Amelia Bruce Zelnak

First Author: Joohyuk Sohn